Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
HTFL
HoldHot AirHeartflow, Inc. · Healthcare · United States · $4.2B · Avg Vol: $90M/d
COMPANY DESCRIPTION
Heartflow, Inc. provides non-invasive, AI-powered technology to diagnose coronary artery disease (CAD), utilizing standard CT scans to create a 3D model of coronary arteries and simulate blood flow. The company's HeartFlow FFRct Analysis offers clinicians a functional assessment of blockages, reducing the need for invasive procedures and improving diagnostic accuracy. Its proprietary technology and FDA clearance establish a strong competitive position in the cardiovascular diagnostics market.
FINANCIAL SUMMARY (USD)
| Year | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|
| Revenue | 87.2M | 125.8M | 176.0M | 42.1% | 212.1M | 248.9M | 309.2M | 32.5% |
| EPS | -1.94 | -1.20 | -3.17 | — | -3.16 | — | — | — |
| Shares | 80.6M | 80.6M | 85.3M | +5.8% | 87.0M | — | — | — |
| Debt | 160.6M | 160.4M | 22.1M | -62.9% | 27.1M | — | — | — |
| Equity | -777.6M | -859.5M | 300.6M | — | — | — | — | — |
| Op CF | -76.4M | -69.0M | -54.0M | — | -52.2M | — | — | — |
| Inv CF | -6.1M | -4.4M | -238.6M | — | — | — | — | — |
| Fin CF | 169.3M | 2.2M | 286.0M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of HTFL are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| HTFL | Heartflow, Inc.(you) | $4.2B | 44 | Hold |
| PRVA | Privia Health Group, Inc. | $2.7B | 51 | Hold |
| DOCS | Doximity, Inc. | $4.8B | 61 | Hold |
| WAY | Waystar Holding Corp. | $5.0B | 62 | Hold |
| CERT | Certara, Inc. | $1.3B | 48 | Hold |
| SDGR | Schrödinger, Inc. | $1.5B | 36 | Hold |
| TXG | 10x Genomics, Inc. | $8.0B | 60 | Hold |
| TDOC | Teladoc Health, Inc. | $1.2B | 49 | Hold |
| TEM | Tempus AI, Inc. | $11.6B | 31 | Sell |
| PHR | Phreesia, Inc. | $751M | 48 | Hold |
Peer medians: ROE -30.5% · P/E 27.0x · Gross margin 58.1%